Met endosomal signalling: In the right place, at the right time

International Journal of Biochemistry and Cell Biology

Volumn 49, Issue 1, 2014, Pages 69-74

  Barrow Mcgee, Rachel ^a   Kermorgant, Stéphanie ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

c Met; Cancer; Cell migration; Endosome; Signalling

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN;

ARTICLE; CELL MIGRATION; CELL SURVIVAL; CELL TRANSFORMATION; ENDOCYTOSIS; ENDOSOME; HUMAN; INTERNALIZATION; INTRACELLULAR SIGNALING; NEOPLASM; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; BIOLOGICAL MODEL; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL TRANSFORMATION, NEOPLASTIC; ENDOCYTOSIS; ENDOSOMES; HUMANS; MODELS, BIOLOGICAL; MUTATION; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 84894202347     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2014.01.009     Document Type: Short Survey

References (54)

1. J.V. Abella, C.A. Parachoniak, V. Sangwan, and M. Park Dorsal ruffle microdomains potentiate Met receptor tyrosine kinase signaling and down-regulation J Biol Chem 285 2010 24956 24967
2. J.V. Abella, P. Peschard, M.A. Naujokas, T. Lin, C. Saucier, and S. Urbe et al. Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation Mol Cell Biol 25 2005 9632 9645
3. F. Bladt, D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier Essential role for the c-Met receptor in the migration of myogenic precursor cells into the limb bud Nature 376 1995 768 771
4. C. Boccaccio, M. Ando, L. Tamagnone, A. Bardelli, P. Michieli, and C. Battistini et al. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway Nature 391 1998 285 288
5. M. Borowiak, A.N. Garratt, T. Wustefeld, M. Strehle, C. Trautwein, and C. Birchmeier Met provides essential signals for liver regeneration Proc Natl Acad Sci USA 101 2004 10608 10613
6. F. Bussolino, M.F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, and L. Naldini et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J Cell Biol 119 1992 629 641
7. S. Carter, S. Urbe, and M.J. Clague The Met receptor degradation pathway: requirement for Lys48-linked polyubiquitin independent of proteasome activity J Biol Chem 279 2004 52835 52839
8. B.P. Ceresa, A.W. Kao, S.R. Santeler, and J.E. Pessin Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways Mol Cell Biol 18 1998 3862 3870
9. K.W. Cheng, J.P. Lahad, W.L. Kuo, A. Lapuk, K. Yamada, and N. Auersperg et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers Nat Med 10 2004 1251 1256
10. J. Chmielowiec, M. Borowiak, M. Morkel, T. Stradal, B. Munz, and S. Werner et al. c-Met is essential for wound healing in the skin J Cell Biol 177 2007 151 162
11. C.S. Cooper, M. Park, D.G. Blair, M.A. Tainsky, K. Huebner, and C.M. Croce et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line Nature 311 1984 29 33
12. J.J. Cui, M. Tran-Dube, H. Shen, M. Nambu, P.P. Kung, and M. Pairish et al. Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK) J Med Chem 54 2011 6342 6363
13. E. Gherardi, W. Birchmeier, C. Birchmeier, and G. Vande Woude Targeting MET in cancer: rationale and progress Nat Rev Cancer 12 2012 89 103
14. D.S. Grant, H.K. Kleinman, I.D. Goldberg, M.M. Bhargava, B.J. Nickoloff, and J.L. Kinsella et al. Scatter factor induces blood vessel formation in vivo Proc Natl Acad Sci USA 90 1993 1937 1941
15. D.E. Hammond, S. Carter, J. McCullough, S. Urbe, G. Vande Woude, and M.J. Clague Endosomal dynamics of Met determine signaling output Mol Biol Cell 14 2003 1346 1354
16. D.E. Hammond, S. Urbe, G.F. Vande Woude, and M.J. Clague Down-regulation of MET, the receptor for hepatocyte growth factor Oncogene 20 2001 2761 2770
17. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
18. S. Ishibe, D. Joly, Z.X. Liu, and L.G. Cantley Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis Mol Cell 16 2004 257 267
19. C. Joffre, R. Barrow, L. Menard, V. Calleja, I.R. Hart, and S. Kermorgant A direct role for Met endocytosis in tumorigenesis Nat Cell Biol 13 2011 827 837
20. T. Kamei, T. Matozaki, T. Sakisaka, A. Kodama, S. Yokoyama, and Y.F. Peng et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells - regulation by Rho, Rac and Rab small G proteins Oncogene 18 1999 6776 6784
21. S. Kermorgant, and P.J. Parker Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation J Cell Biol 182 2008 855 863
22. S. Kermorgant, D. Zicha, and P.J. Parker Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met J Biol Chem 278 2003 28921 28929
23. S. Kermorgant, D. Zicha, and P.J. Parker PKC controls HGF-dependent c-Met traffic, signalling and cell migration EMBO J 23 2004 3721 3734
24. A.Z. Lai, M. Durrant, D. Zuo, C.D. Ratcliffe, and M. Park Met kinase-dependent loss of the E3 ligase Cbl in gastric cancer J Biol Chem 287 2012 8048 8059
25. N. Li, M. Lorinczi, K. Ireton, and L.A. Elferink Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase J Biol Chem 282 2007 16764 16775
26. L.S. Lock, C.R. Maroun, M.A. Naujokas, and M. Park Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis Mol Biol Cell 13 2002 2132 2146
27. C.R. Maroun, M.A. Naujokas, M. Holgado-Madruga, A.J. Wong, and M. Park The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase Mol Cell Biol 20 2000 8513 8525
28. M. Miaczynska, L. Pelkmans, and M. Zerial Not just a sink: endosomes in control of signal transduction Curr Opin Cell Biol 16 2004 400 406
29. G.K. Michalopoulos, and M.C. DeFrances Liver regeneration Science 276 1997 60 66
30. A. Montagner, A. Yart, M. Dance, B. Perret, J.P. Salles, and P. Raynal A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation J Biol Chem 280 2005 5350 5360
31. P.A. Muller, P.T. Caswell, B. Doyle, M.P. Iwanicki, E.H. Tan, and S. Karim et al. Mutant p53 drives invasion by promoting integrin recycling Cell 139 2009 1327 1341
32. P.A. Muller, A.G. Trinidad, P. Timpson, J.P. Morton, S. Zanivan, and P.V. van den Berghe et al. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion Oncogene 32 2013 1252 1265
33. D. Naka, T. Shimomura, Y. Yoshiyama, M. Sato, M. Sato, and T. Ishii et al. Internalization and degradation of hepatocyte growth factor in hepatocytes with down-regulation of the receptor/c-Met FEBS Lett 329 1993 147 152
34. T. Nakamura, S. Mizuno, K. Matsumoto, Y. Sawa, and H. Matsuda Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF J Clin Invest 106 2000 1511 1519
35. L.E. O'Brien, K. Tang, E.S. Kats, A. Schutz-Geschwender, J.H. Lipschutz, and K.E. Mostov ERK and MMPs sequentially regulate distinct stages of epithelial tubule development Dev Cell 7 2004 21 32
36. A. Palamidessi, E. Frittoli, M. Garre, M. Faretta, M. Mione, and I. Testa et al. Endocytic trafficking of Rac is required for the spatial restriction of signaling in cell migration Cell 134 2008 135 147
37. C.A. Parachoniak, Y. Luo, J.V. Abella, J.H. Keen, and M. Park GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration Dev Cell 20 2011 751 763
38. M. Park, M. Dean, K. Kaul, M.J. Braun, M.A. Gonda, and G. Vande Woude Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors Proc Natl Acad Sci USA 84 1987 6379 6383
39. G. Pelicci, S. Giordano, Z. Zhen, A.E. Salcini, L. Lanfrancone, and A. Bardelli et al. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein Oncogene 10 1995 1631 1638
40. A. Petrelli, G.F. Gilestro, S. Lanzardo, P.M. Comoglio, N. Migone, and S. Giordano The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met Nature 416 2002 187 190
41. C. Ponzetto, A. Bardelli, Z. Zhen, F. Maina, P. dalla Zonca, and S. Giordano et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family Cell 77 1994 261 271
42. A.J. Ridley, P.M. Comoglio, and A. Hall Regulation of scatter factor/hepatocyte growth factor responses by Ras. Rac, and Rho in MDCK cells Mol Cell Biol 15 1995 1110 1122
43. M. Sachs, H. Brohmann, D. Zechner, T. Muller, J. Hulsken, and I. Walther et al. Essential role of Gab1 for signaling by the c-Met receptor in vivo J Cell Biol 150 2000 1375 1384
44. V. Sangwan, J. Abella, A. Lai, N. Bertos, M. Stuible, and M.L. Tremblay et al. Protein-tyrosine phosphatase 1B modulates early endosome fusion and trafficking of Met and epidermal growth factor receptors J Biol Chem 286 2011 45000 45013
45. C. Schmidt, F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, and M. Sharpe et al. Scatter factor/hepatocyte growth factor is essential for liver development Nature 373 1995 699 702
46. P.A. Singleton, R. Salgia, L. Moreno-Vinasco, J. Moitra, S. Sammani, and T. Mirzapoiazova et al. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin J Biol Chem 282 2007 30643 30657
47. L. Trusolino, A. Bertotti, and P.M. Comoglio MET signalling: principles and functions in development, organ regeneration and cancer Nat Rev Mol Cell Biol 11 2010 834 848
48. Y. Uehara, O. Minowa, C. Mori, K. Shiota, J. Kuno, and T. Noda et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor Nature 373 1995 702 705
49. E. Veiga, and P. Cossart Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells Nat Cell Biol 7 2005 894 900
50. G.H. Xiao, M. Jeffers, A. Bellacosa, Y. Mitsuuchi, G.F. Vande Woude, and J.R. Testa Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways Proc Natl Acad Sci USA 98 2001 247 252
51. J. Zhang, X. Liu, A. Datta, K. Govindarajan, W.L. Tam, and J. Han et al. RCP is a human breast cancer-promoting gene with Ras-activating function J Clin Invest 119 2009 2171 2183
52. Y.W. Zhang, L.M. Wang, R. Jove, and G.F. Vande Woude Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis Oncogene 21 2002 217 226
53. H.Y. Zou, Q. Li, J.H. Lee, M.E. Arango, K. Burgess, and M. Qiu et al. Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor Mol Cancer Ther 11 2012 1036 1047
54. H.Y. Zou, Q. Li, J.H. Lee, M.E. Arango, S.R. McDonnell, and S. Yamazaki et al. An orally available small-molecule inhibitor of c-Met. PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms Cancer Res 67 2007 4408 4417